Immunova to Acquire AlphaTON Subsidiary Iox Therapeutics
Immunova has moved to acquire AlphaTON's cancer-treatment subsidiary, Iox Therapeutics, in a deal that signals a stra...
Understand which index funds to hold in retirement 2024, with practical tips on allocation, rebalancing, and long-term performance.
24,838 articlesImmunova has moved to acquire AlphaTON's cancer-treatment subsidiary, Iox Therapeutics, in a deal that signals a stra...
A cruise stock jumps as an activist investor takes a stake, signaling potential governance shifts. This article break...
Winter demand and a growing data-center footprint push grid strain. The Trump administration accelerates a coal reviv...
As fuel costs climb, airline stocks stumble and investors reassess 2026 earnings prospects. This piece breaks down wh...
Metallus faces a dynamic metals market in 2025. This guide breaks down expected MTUS 2025 earnings, the drivers behin...
Opendoor stock popped today amid optimism about profitability progress and better unit economics. This article breaks...
A 61-year-old CEO at a major U.S. insurer shapes a six-day workout schedule, guided by his 23-year-old son, while ste...
Moderna surged on pandemic-era demand. But what comes next? This piece examines why some investors are wary, what a t...
This article analyzes Summit's Q4 2025 earnings context, what the numbers could imply for the summit (smmt) 2025 earn...
As Elanco maps out its path for 2025, investors weigh growth drivers, margins, and catalysts. This guide breaks down ...
Mortgage lenders accelerate the shift to digital promissory notes as funding timelines tighten. The trend signals eno...
Two NYPD officers were hospitalized after being pelted with snowballs during a large-scale snowball fight in Washingt...